Geoff Fatzinger

Mr. Fatzinger is the Q BioMed Head of Global Regulatory Affairs, responsible for providing strategic regulatory oversight to Q BioMed product development and commercialization. Geoff is a highly experienced, results-oriented global regulatory professional, with very strong strategic capabilities and a very solid technical background that has allowed him to lead companies and projects to new levels of success in a variety of highly competitive industries, cutting-edge markets, and fast-paced environments.

Geoff brings 20+ years of expertise and a demonstrated record of regulatory and business accomplishments covering the United States, Europe, Asia Pacific (with in depth experience in Japan, China, and Korea), and Middle East having lived and worked in many countries championing regulatory affairs.

His proven abilities in the successful creation and implementation of global regulatory strategies from concept to commercialization, business planning, global growth strategies, in-licensing and commercial valuations has helped numerous companies reach their business objectives on a global scale.

He has been directly involved in all phases of product development globally. His specialties include global and product regulatory strategy development; market assessments; agency interactions; HEOR and Regulatory Economics; extensive global experience in drug and device development; clinical trials, and approvals, including such areas as: biosimilar development and approval; nanotechnology, stem cell and gene therapy products, medical devices; in-licensing and divestitures; and regulatory due diligence.

Geoff is a frequent lecturer on international regulatory affairs and regulatory law, as well as a contributing member to several organizations including TOPRA and lecturer at Cranfield for the Regulatory Affairs education programs.